The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSavills Share News (SVS)

Share Price Information for Savills (SVS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,108.00
Bid: 1,108.00
Ask: 1,110.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.181%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,108.00
SVS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

17 Mar 2011 07:21

Savills unveils new divi policy as profits boom

Global property markets are bouncing back strongly judging by the results from international estate agent Savills, with Asia Pacific putting in an especially strong performance. Group revenue for 2010 was up 21%, or 19% in constant currency (cc) terms to £677.0m from £560.7m in 2009. Underlying pr

Read more
8 Nov 2010 16:43

London close: FTSE 100 slips back

Shares were on balance slightly lower as trading closed, with investors continuing to pause for breath following the strong gains seen last week on the back of the renewal of quantitative easing in the US. Rolls-Royce was a late riser after the aero-engineer said it was making progress n its invest

Read more
8 Nov 2010 13:47

London afternoon: Investors cautious ahead of G20 meeting

The Footsie drifted lower over the lunchtime session, hitting a new low for the day, as the afterglow of the Fed's quantitative easing boost begins to fade. There was also an element of caution ahead of this week's Group of 20 meeting in South Korea. It's been an unusually busy Monday for company r

Read more
8 Nov 2010 12:28

London midday: Footsie drifts lower

Leading shares are mixed but still trending lower, with cautious investors banking a few profits after the UK market rose more than 3% last week. US futures point to a dull start on Wall Street, which is not helping shift the lacklustre mood. The Dow is tipped to start about 15 points below last we

Read more
8 Nov 2010 08:40

London open: Unspectacular start for blue chips

After the tumultuous events of last week London has paused for breath, with Footsie making only slight gains early on. The G20 summit will make headlines later in the week, but for now investors are bracing themselves for a deluge of blue chip announcements over the next few days. Warming up for t

Read more
8 Nov 2010 07:49

Savills sees FY profit in excess of £40m

Real estate advisor Savills expects underlying pre-tax profit for the year to 31 December 2010 to be in excess of £40m helped by a particularly strong performance in Asia and the UK. Transactions at its Prime London Residential business have continued at a healthy level, the group said, albeit four

Read more
2 Jul 2010 07:45

UK MARKET TALK ROUNDUP: BROKERS COMMENTS

Broker comments in the UK today. Compiled by Dow Jones Newswires Markets Desk, markets.eu@dowjones.com Contact us in London. +44-20-7842-9464 Markettalk.eu@dowjones.com 0645 GMT [Dow Jones] UBS upgrades Savills (SVS.LN) to buy from neutral. Says the shares have declined by 25% from their peak

Read more
2 Jul 2010 07:45

MARKET TALK: UBS Upgrades Savills To Buy From Neutral

0645 GMT [Dow Jones] UBS upgrades Savills (SVS.LN) to buy from neutral. Says the shares have declined by 25% from their peak in mid-March. Thinks this represents an attractive entry point. Cuts the price target to 300p from 360p. Meanwhile, expects a strong 1H, reflecting a continuation of the momen

Read more
22 Jun 2010 03:36

Savills CEO: 2010 Revenue Growth From China May Slow To 20%

SHANGHAI (Dow Jones)--London-listed real-estate adviser Savills PLC's (SVS.LN) revenue growth from its China business may slow to around 20% this year from the average 30% in the last three years, as activity in the Chinese property market will likely cool, Chief Executive Jeremy Helsby said Monday.

Read more
9 Jun 2010 16:24

Banks Still Aim To Cut UK Property Loans But See No Sales Soon

By Anita Likus Of DOW JONES NEWSWIRES LONDON (Dow Jones)--While U.K. banks are still seeking to reduce their commercial property loan books, industry experts aren't holding their breath for waves of property disposals and urged potential buyers to be patient. Speaking at Savills PLC's (

Read more
29 Mar 2010 07:56

Savills buys Australia's Incoll Management

Real estate advisor Savills has agreed to buy Incoll Management, an Australian project management and building consultancy business, for AUS$13m (£8m). All consideration payments will be settled in cash out of existing resources, including debt facilities, the group said. Incoll, which provides p

Read more
24 Mar 2010 16:49

Cairn boss raises nearly £3m

Cairn Energy chief executive Sir Bill Gammell has raised nearly £3m from a share sale. Sir Bill sold 721,042 shares in the oil and gas producer and explorer at 414.4p each. He retains 3.21m shares, which is equivalent to 0.23% of the company's share capital. There have been two other sales by Si

Read more
19 Mar 2010 06:45

Friday tips round-up: Investec, Savills, Aegis

Shares in Investec, the South African lender with a dual listing in London, have gained 26% since the start of the year ? a performance that will see it promoted to the FTSE 100 index for the first time next week. Overall, Investec has risen more than threefold in value since floating over here in 2

Read more
18 Mar 2010 16:35

London close: Weak finish as banks retreat

London closed in the red after a mixed opening on Wall Street as banks and miners ran into profit taking. Among the big caps, GlaxoSmithKline was the best performer, after rival drug group, Switzerland's Novartis, had to hand back US rights of a drug widely considered a generic copy of Glaxo's top

Read more
18 Mar 2010 15:19

London afternoon: Back to square one

A mixed opening on Wall Street has provided no guidance for a similarly rudderless London market. Among the big caps, GlaxoSmithKline is the best performer, after rival drug group, Switzerland's Novartis, had to hand back US rights of a drug widely considered a generic copy of Glaxo's top selling

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.